Alnylam Pharmaceuticals
ALNY
#585
Rank
A$52.12 B
Marketcap
$406.00
Share price
2.04%
Change (1 day)
41.12%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: A$52.12 Billion

As of September 2024 Alnylam Pharmaceuticals has a market cap of A$52.12 Billion. This makes Alnylam Pharmaceuticals the world's 585th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2024

End of year Market Cap

Year Market cap Change
2024A$52.12 B47.84%
2023A$35.25 B-17.94%
2022A$42.96 B54.03%
2021A$27.89 B42.34%
2020A$19.59 B6.61%
2019A$18.38 B75.59%
2018A$10.46 B-35.14%
2017A$16.13 B262.08%
2016A$4.45 B-59.47%
2015A$10.99 B20.42%
2014A$9.13 B98.74%
2013A$4.59 B397.34%
2012A$0.92 B172.05%
2011A$0.33 B-17.64%
2010A$0.41 B-49.97%
2009A$0.82 B-44.42%
2008A$1.48 B9.28%
2007A$1.35 B34.91%
2006A$1.00 B185.67%
2005A$0.35 B89.15%
2004A$0.18 B

End of Day market cap according to different sources

On Sep 15th, 2024 the market cap of Alnylam Pharmaceuticals was reported to be:

A$51.07 Billion
by Yahoo Finance info icon info icon
A$51.07 Billion
by CompaniesMarketCap info icon info icon
A$51.07 Billion
by Nasdaq info icon info icon

Market capitalization for similar companies or competitors

Name Market cap Market cap differencediff. Country
A$3.86 B-92.58%๐Ÿ‡บ๐Ÿ‡ธ USA
A$191.39 B 267.21%๐Ÿ‡บ๐Ÿ‡ธ USA
A$17.86 B-65.72%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.70 B-96.73%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.15 B-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
A$354.61 B 580.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
A$215.71 B 313.85%๐Ÿ‡ซ๐Ÿ‡ท France
A$30.85 B-40.80%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel